{"schema":"hottub-news/story/v1","story":"st_o2ioyaazvnocgtvhm4ia","title":"FDA approves Sunharbo, factor XIa inhibitor for reducing stroke","title_en":"FDA approves Sunharbo, factor XIa inhibitor for reducing stroke","outlets":6,"brief":null,"page":"https://hottub.news/stories/bayers-sunharbo-wins-fda-approval-as-first-factor-xia-blood-thinner-to-o2ioyaazvn","count":6,"items":[{"id":"n_f53ibs7aohznedb3ymlq","seq":10351345,"kind":"article","title":"Factor XIa Inhibitor Sunharbo Approved for Secondary Stroke Prevention","url":"https://www.renalandurologynews.com/news/fda-approves-sunharbo-asundexian-secondary-stroke-prevention","published":"2026-11-12T14:48:00Z","seen":"2026-11-12T16:30:52Z","lang":"en","source":{"id":"renalandurologynews.com","name":"renalandurologynews.com","domain":"renalandurologynews.com"},"via":"gdelt-gkg-english","topics":["economy","science","education","health"],"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.49000000953674316,"category2":"science-technology","sentiment":"positive","tone":-0.09000000357627869,"political":0.03999999910593033},{"id":"n_awxqghv6fgnwpee346ba","seq":9967802,"kind":"article","title":"Factor XIa Inhibitor Sunharbo Approved for Secondary Stroke Prevention","url":"https://www.empr.com/news/fda-approves-sunharbo-asundexian-secondary-stroke-prevention","published":"2026-11-11T15:55:00Z","seen":"2026-11-11T18:10:43Z","lang":"en","source":{"id":"empr.com","name":"empr.com","domain":"empr.com"},"via":"gdelt-gkg-english","topics":["economy","health","education","science"],"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.49000000953674316,"category2":"science-technology","sentiment":"positive","tone":-0.09000000357627869,"political":0.03999999910593033},{"id":"n_seclaopsit7w6rdg2bfa","seq":9977212,"kind":"article","title":"Factor XIa Inhibitor Sunharbo Approved for Secondary Stroke Prevention","url":"https://www.neurologyadvisor.com/news/fda-approves-sunharbo-asundexian-secondary-stroke-prevention","published":"2026-11-11T13:45:00Z","seen":"2026-11-11T18:37:29Z","lang":"en","source":{"id":"neurologyadvisor.com","name":"neurologyadvisor.com","domain":"neurologyadvisor.com"},"via":"gdelt-gkg-english","topics":["economy","education","science","health"],"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.49000000953674316,"category2":"science-technology","sentiment":"positive","tone":-0.09000000357627869,"political":0.03999999910593033},{"id":"n_3aj4axl5tye2lebr735q","seq":9750550,"kind":"article","title":"U.S. Clears Sunharbo as First Factor XIa Inhibitor for Stroke Risk","url":"https://econotimes.com/U-S-Clears-Sunharbo-as-First-Factor-XIa-Inhibitor-for-Stroke-Risk-1775026","published":"2026-11-11T06:45:00Z","seen":"2026-11-11T07:05:00Z","lang":"en","source":{"id":"econotimes.com","name":"econotimes.com","domain":"econotimes.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.5299999713897705,"sentiment":"positive","tone":-0.3799999952316284,"political":0.18000000715255737},{"id":"n_smclfzhf6agnxx7bhztq","seq":9558166,"kind":"article","title":"FDA approves Sunharbo, factor XIa inhibitor for reducing stroke","url":"https://www.healio.com/news/neurology/20261110/fda-approves-sunharbo-first-factor-xia-inhibitor-for-reducing-risk-for-secondary-stroke","summary":"The FDA has approved Sunharbo, the only approved factor XIa inhibitor intended to reduce the risk for stroke in adults who recently experienced a non-cardioembolic ischemic stroke or high-risk transient ischemic attack. With the approval, physicians now have a treatment option that can lower patient risk for secondary stroke, which can come with more severe outcomes than incident strokes, said Ashkan Shoamanesh, MD, senior scientist with the Population Health Research…","published":"2026-11-10T18:31:57Z","seen":"2026-11-10T18:52:50Z","lang":"en","source":{"id":"kite-healio-com-23151b","name":"healio.com","domain":"healio.com"},"via":"kite-healio-com-23151b","topics":["medicine"],"authors":["Shawn Arrajj"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":2,"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.46000000834465027,"category2":"science-technology","sentiment":"positive","tone":0.36000001430511475,"political":0.12999999523162842},{"id":"n_o2ioyaazvnocgtvhm4ia","seq":9348932,"kind":"article","title":"Bayer's Sunharbo Wins FDA Approval as First Factor XIa Blood Thinner to Cut Repeat Stroke Risk by 26%","url":"https://www.medicaldaily.com/fda-approves-sunharbo-recurrent-stroke-risk-481034","summary":"The FDA approved Bayer's once-daily Sunharbo for adults recovering from certain ischemic strokes or high-risk TIAs, while trial results showed reduced recurrence but unresolved long-term bleeding questions.","published":"2026-11-10T06:51:32Z","seen":"2026-11-10T07:30:01Z","lang":"en","country":"US","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"story":"st_o2ioyaazvnocgtvhm4ia","category":"health","category_p":0.7200000286102295,"sentiment":"positive","tone":0.5400000214576721,"political":0.029999999329447746}]}